Colorcon increases Suglets manufacturing capacity by 50%

Investments being made ahead of anticipated demand.

"As growth continues for multiparticulate dosage forms, especially for geriatric and pediatric populations, there is an ongoing need in the industry for a consistent supplier who provides a high-quality sphere for multiparticulate products, with a robust business continuity plan. New investments, which increase our annual capacity by 50%, are being made ahead of anticipated demand to manage product availability efficiently for our customers,” says Deborah Taylor, Global Market Communications Manager.

"At Colorcon, we have continued to improve and expand our sphere operations to offer the best quality product from our two Suglets manufacturing locations, Stoughton, Wisconsin, US, and Bazainville, France. As the only manufacturer dedicated to the production of spheres for pharmaceutical use, we have the ability to produce equivalent products from both sites, providing much-desired business continuity.”